North America Digital Therapeutics Market is expected to reach US$ 7,833 Mn by 2024 from US$ 1,751 Mn in 2016 at CAGR of 20.5% during a forecast period.North America Digital Therapeutics Market North America Digital Therapeutics market is segmented by Sales channel, By Application & by Geography. The sales channel is classified into B2B & B2C. By application, a market is divided into Preventive Applications, Treatment/Care-Related Applications.

Digital therapeutics, commonly known as software for drugs has been increasing much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient’s vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important drivers offered by digital therapeutics. Rising in internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention.

On the basis of sale channel. Sales channel segment is bifurcated as B2B and B2C. B2B segment is expected to lead the market growth. This growth is attributed to the rising adoption of digital therapeutics in this segment, especially among payers and employers.
Based on application, the Preventive application segment is expected to dominate the market growth owing to, increasing government initiatives to increase the focus on preventive healthcare and a rising consensus among policymakers.

North America is one of the major markets for Digital Therapeutics globally where U.S. and Canada are the two major regions profiled under this report. The U.S. has been reported to spend USD 3.2 trillion a year on healthcare. In order to control this expense, there is a rising focus on preventive healthcare, to indorse overall patient wellness as an alternative to medical treatment.
Key players operate on the market are, Evolent Health, Inc., Pear Therapeutics, Inc. WellDoc Inc. Nanobiosym, Inc., Twine Health, Inc.,Mango Health Inc., Canary Health Inc., 2morrow Inc., Propeller Health, Ginger.Io, Inc., Noom Inc., Livongo Health, Omada Health, Inc., Proteus Digital Health, Inc.
The Scope of the North America Digital Therapeutics Market
For more information visit
https://www.maximizemarketresearch.com/market-report/north-america-digital-therapeutics-market/7077/
North America Digital Therapeutics market, By Sale channel

• B2B
• B2C
North America Digital Therapeutics Market, By Application

• Preventive Applications
• Treatment/Care-Related Applications
North America Digital Therapeutics Market, By Region

• North America
• U.S.
• Canada
Key Players operating in the North America Digital Therapeutics market

• Evolent Health, Inc.
• Pear Therapeutics, Inc.
• WellDoc Inc.
• Nanobiosym, Inc.
• Twine Health, Inc.
• Mango Health Inc.
• Canary Health Inc.
• 2morrow Inc.
• Propeller Health
• Ginger.Io, Inc.
• Noom Inc.
• Livongo Health
• Omada Health, Inc.
• Proteus Digital Health, Inc.

This Report Is Submitted By Maximize Market Research
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [email protected]
Address: Maharashtra 411051, India.
Contact:+919607365656